1998
DOI: 10.1016/s0923-2494(98)80070-9
|View full text |Cite
|
Sign up to set email alerts
|

P40: a promising new carrier protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2007
2007

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…This protein was demonstrated to be as potent as the reference carrier tetanus toxoid already used in human conjugate vaccines since it was able to induce strong antibody responses against B cell epitopes, such as peptides [16,17] and bacterial polysaccharides [17][18][19] coupled to it. Moreover, the protein also works as a potent immunological adjuvant for specific cytotoxic T lymphocyte (CTL) response induction in vivo [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…This protein was demonstrated to be as potent as the reference carrier tetanus toxoid already used in human conjugate vaccines since it was able to induce strong antibody responses against B cell epitopes, such as peptides [16,17] and bacterial polysaccharides [17][18][19] coupled to it. Moreover, the protein also works as a potent immunological adjuvant for specific cytotoxic T lymphocyte (CTL) response induction in vivo [20,21].…”
Section: Introductionmentioning
confidence: 99%